Literature DB >> 1172815

Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom.

W W Busse, C E Reed, L M Lichtenstein, R E Reisman.   

Abstract

After nine months of immunotherapy with commercially prepared wholebody bee extract, a beekeeper's wife experienced anaphylaxis after a controlled bee-sting challenge. High risk of future bee stings prompted a decision to attempt desensitization with honeybee venom. This was extracted from the bee into Coca solution and administered parenterally in increasing daily doses until an equivalent of one venom sac was given per day. This maintenance dosage was continued for a month. Anaphylaxis did not occur after another bee-sting challenge. Therapy has been maintained with venom. With this treatment, there has been an increase in the level of IgG-blocking antibody and a fall in IgE titer to bee venom (radioallergosorbent test [RAST]).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1172815

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  4 in total

1.  Venom immunotherapy for stinging insect allergy.

Authors:  D F Graft
Journal:  Clin Rev Allergy       Date:  1987-05

2.  Diagnosis and prevalence of stinging insect allergy.

Authors:  D B Golden
Journal:  Clin Rev Allergy       Date:  1987-05

3.  Enzyme-linked immunosorbent assay of allergen-specific IgG antibodies in bee sting allergic patients hyposensitized with pure bee venom.

Authors:  J Forster; R Urbanek
Journal:  Klin Wochenschr       Date:  1979-04-17

Review 4.  The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword.

Authors:  Jun Chen; William R Lariviere
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.